21 – 30 of 35
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.
(
- Contribution to journal › Article
- 2011
-
Mark
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
(
- Contribution to journal › Article
-
Mark
Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies
(
- Contribution to journal › Article
- 2010
-
Mark
Three different antibodies for estrogen receptor analysis in breast cancer - implications for positive frequency, reproducibility and clinical outcome
(
- Contribution to journal › Published meeting abstract
-
Mark
Ki67 proliferation as a biomarker in neo-adjuvant breast cancer studies - core biopsy versus surgical sample
(
- Contribution to journal › Published meeting abstract
-
Mark
Ki-67 as a long-term prognostic factor in lobular breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer.
2010) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 23. p.251-259(
- Contribution to journal › Article
-
Mark
AIB1 is a predictive factor for tamoxifen response in premenopausal women.
(
- Contribution to journal › Article
-
Mark
Identification of Subtypes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome.
(
- Contribution to journal › Article
- 2009
-
Mark
Significantly higher expression of vascular endothelial growth factor (VEGF) and shorter survival after recurrences in premenopausal node negative patients with triple negative breast cancer
(
- Contribution to journal › Published meeting abstract